Tisagenlecleucel (CTL019)

tisagenlecleucel · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tisagenlecleucel (CTL019), covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Managed Access Programs for CTL019, Tisagenlecleucel